32nd European Society of Intensive Care Medicine (ESICM) LIVES
28 September – 2 October | CityCube, Berlin, Germany
Talk: October 1st, 16:20 CET, room Stockholm.
“Adrenomedullin in sepsis, effect of the non-inhibitory antibody Adrecizumab”, session “Innovation in sepsis treatment”, Prof. Dr. Peter Pickkers, Radboud University, Department of Intensive Care, Nijmegen, The Netherlands.
